Chaur‐Shine Wang

407 total citations
13 papers, 289 citations indexed

About

Chaur‐Shine Wang is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chaur‐Shine Wang has authored 13 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Chaur‐Shine Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Chaur‐Shine Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Chaur‐Shine Wang collaborates with scholars based in Taiwan, United States and Japan. Chaur‐Shine Wang's co-authors include Li‐Ying Liao, Jia‐Horng Kao, Pei‐Jer Chen, Ding‐Shinn Chen, Chih‐Lin Lin, Ming–Yang Lai, Yao‐Chun Hsu, Hwai‐Jeng Lin, Ming‐Feng Chiang and Wei‐Lun Hsu and has published in prestigious journals such as American Journal of Roentgenology, World Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Chaur‐Shine Wang

12 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaur‐Shine Wang Taiwan 9 186 165 73 43 36 13 289
Yoshirou Baba Japan 6 307 1.7× 218 1.3× 128 1.8× 63 1.5× 38 1.1× 9 393
Manuel Delgado Spain 9 112 0.6× 133 0.8× 77 1.1× 35 0.8× 39 1.1× 19 269
Stéphane Corbinais France 8 80 0.4× 68 0.4× 78 1.1× 39 0.9× 44 1.2× 16 202
Cheng‐Chung Tsai Taiwan 9 179 1.0× 104 0.6× 170 2.3× 90 2.1× 82 2.3× 16 322
Yanfang Zhao China 5 232 1.2× 149 0.9× 125 1.7× 31 0.7× 85 2.4× 6 296
Yong Kyun Cho South Korea 6 111 0.6× 105 0.6× 249 3.4× 121 2.8× 147 4.1× 7 322
Jean-Jacques Wenger France 5 425 2.3× 216 1.3× 115 1.6× 81 1.9× 39 1.1× 6 457
Apostolos Koffas United Kingdom 11 99 0.5× 193 1.2× 41 0.6× 21 0.5× 89 2.5× 31 286
Sepideh Besharati United States 10 90 0.5× 72 0.4× 165 2.3× 70 1.6× 108 3.0× 27 317
Tanita Suttichaimongkol Thailand 5 109 0.6× 64 0.4× 42 0.6× 20 0.5× 30 0.8× 18 155

Countries citing papers authored by Chaur‐Shine Wang

Since Specialization
Citations

This map shows the geographic impact of Chaur‐Shine Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaur‐Shine Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaur‐Shine Wang more than expected).

Fields of papers citing papers by Chaur‐Shine Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaur‐Shine Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaur‐Shine Wang. The network helps show where Chaur‐Shine Wang may publish in the future.

Co-authorship network of co-authors of Chaur‐Shine Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chaur‐Shine Wang. A scholar is included among the top collaborators of Chaur‐Shine Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaur‐Shine Wang. Chaur‐Shine Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hsu, Yao‐Chun, Lein‐Ray Mo, Chi‐Yang Chang, et al.. (2016). Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients. Clinical Gastroenterology and Hepatology. 14(10). 1490–1498.e3. 34 indexed citations
2.
Hsu, Yao‐Chun, et al.. (2010). Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. British Journal of Clinical Pharmacology. 70(2). 171–179. 20 indexed citations
3.
Hsu, Yao‐Chun, Chin‐Lin Perng, Chaur‐Shine Wang, et al.. (2009). A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding. British Journal of Clinical Pharmacology. 69(3). 245–251. 14 indexed citations
4.
Hsu, Ching‐Sheng, et al.. (2005). Retroperitoneal Liposarcoma: Report of a Case. 22(2). 136–144.
5.
Wang, Chaur‐Shine. (2005). Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma. World Journal of Gastroenterology. 11(39). 6115–6115. 74 indexed citations
6.
Lin, Chih‐Lin, Li‐Ying Liao, Chaur‐Shine Wang, et al.. (2005). Basal core‐promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen‐negative chronic hepatitis B. Liver International. 25(3). 564–570. 63 indexed citations
7.
Chen, Kuan-Yang, Chaur‐Shine Wang, Chien‐Fu Hung, et al.. (2004). Percutaneous Radio-Frequency Ablation of Liver Malignancies. 1(2). 245–248. 1 indexed citations
8.
Lin, Chih‐Lin, Li‐Ying Liao, Chaur‐Shine Wang, et al.. (2004). Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg‐positive chronic hepatitis B patients receiving lamivudine therapy. Liver International. 24(1). 9–15. 16 indexed citations
9.
Liao, Li‐Ying, et al.. (2003). Carbon Dioxide–Enhanced Sonographically Guided Percutaneous Ethanol Injection: Treatment of Patients with Viable and Recurrent Hepatocellular Carcinoma. American Journal of Roentgenology. 181(6). 1647–1652. 8 indexed citations
10.
Chen, Ran‐Chou, et al.. (2002). Assessment of Vascularity in Hepatic Tumors. American Journal of Roentgenology. 178(1). 67–73. 7 indexed citations
11.
Chen, Ran‐Chou, et al.. (1998). Intra‐arterial carbon dioxide‐enhanced ultrasonogram of hepatocellular carcinoma treated by transcatheter arterial embolization and percutaneous ethanol injection therapy. Journal of Gastroenterology and Hepatology. 13(1). 41–46. 10 indexed citations
12.
Liao, Li‐Ying, et al.. (1998). Alcohol/Related Problems in Taiwan with Particular Emphasis on Alcoholic Liver Diseases. Alcoholism Clinical and Experimental Research. 22(Supplement 1). 164–164. 7 indexed citations
13.
Wang, Chaur‐Shine, et al.. (1984). Cholangiocarcinoma in Hepatolithiasis. Journal of Clinical Gastroenterology. 6(6). 539–547. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026